Blog

Pharma Is Losing $250 Billion to Patient Dropout. Here’s the Fix the Industry Can’t Ignore

Today we released a press announcement that addresses something pharma leaders already feel in their forecasts, but rarely quantify directly: Patient dropout is quietly draining $250 billion from the U.S. pharmaceutical market every year. You can read the full announcement here:https://www.prnewswire.com/news-releases/pharma-is-losing-250-billion-to-patient-dropout-heres-how-to-stop-it-302696178.html Not because therapies do not work. Not because innovation has slowed. But because patients […]

Read more

Why Prescriptions Aren’t Converting Into Therapy Starts

Pharmaceutical brands are delivering extraordinary science to market. Yet an increasing percentage of prescribed patients never initiate therapy. Not because the product does not work.Not because physicians are not prescribing it. But because the moment education leaves the physician’s hands, initiation risk skyrockets. The hidden gap between prescription and start From a brand perspective, the […]

Read more

Why Patient Services Is Breaking as Pharma Goes Direct to Patient

Listen to Episode 1: Pharma’s Direct to Patient Pivot: What to Expect in 2026 here. The pharmaceutical industry is moving faster than patients can keep up. Therapies are becoming more specialized. Disease education is more complex. Access models are shifting Direct to Patient. At the same time, physician time is shrinking and patients are being […]

Read more

Direct-to-Patient Is Scaling Fast in Pharma, and Patient Confusion Is the Hidden Risk

Enterprise pharma is moving decisively toward direct-to-patient models. This is not a marketing trend or a side project. It is a structural response to access friction, pricing pressure, and the consumerization of healthcare. Patients are behaving more like consumers, distribution models are shifting, and manufacturers are being pulled closer to the patient experience whether they […]

Read more

The Cognitive Burden of Specialty Therapies and Its Impact on Adherence

Specialty therapies are increasingly effective, targeted, and personalized. At the same time, they are becoming more complex for patients to manage. Treatment success in specialty care often depends not only on clinical efficacy but on a patient’s ability to understand, remember, and consistently act on treatment requirements over time. These cognitive demands are rarely measured, […]

Read more

What ChatGPT Health Signals for the Future of Patient Education

The recent ChatGPT Health announcement has sparked significant discussion across healthcare. With more than 40 million people asking ChatGPT a healthcare question every day, the reality is clear. Patients have already been using AI to fill a gap that has existed for years. That gap is not a lack of clinical expertise. It is a […]

Read more

How Patients Actually Learn About Their Treatment Versus How We Assume They Do

Healthcare organizations invest significant time and resources into educating patients about their treatments. Clinicians explain diagnoses, outline care plans, distribute written materials, and direct patients to digital resources. Yet across specialty care, a persistent gap exists between how education is delivered and how patients actually learn. This gap has meaningful implications. Specialty therapies are often […]

Read more

Why Patient Education Is the Most Undermeasured Variable in Specialty Treatment Success

Specialty treatments now represent a growing share of healthcare utilization, cost, and clinical complexity. Hospitals, specialty practices, and pharmaceutical manufacturers invest heavily in innovation, access programs, care coordination, and clinical excellence. Yet one variable continues to receive disproportionately little measurement, governance, or accountability. Patient education.* Despite its central role in treatment initiation, adherence, and long-term […]

Read more

What FDA-Approved Stellest Lenses Mean for Myopia Management in 2026

The start of a new year is when many practices reassess growth. Not just revenue growth, but clinical growth. Program maturity. Patient outcomes. In pediatric eye care, few areas deserve that reflection more than myopia management. As myopia prevalence continues to rise, the question is no longer whether to intervene, but how early, how consistently, […]

Read more

Patient Education Is Broken. And It Is Costing Doctors More Than They Think.

At the Hoot Specialty Treatment Success Center, we study one thing relentlessly. How patients actually get educated. Not how doctors think they educate. Not how brochures promise education works. How it really happens in the real world, inside busy practices, with distracted patients, limited time, and high financial stakes. Here is the uncomfortable truth. Most […]

Read more